These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 572908)

  • 1. [Experiments for the development of a hepatitis B vaccine: immunogenicity of HBsAg in guinea pigs (author's transl)].
    Stamm B; Gerlich W; Thomssen R
    Med Microbiol Immunol; 1979 May; 167(2):83-97. PubMed ID: 572908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A vaccine prepared from the 22 nm particles of surface hepatitis B antigen (HBsAg).
    Karelin VP; Babaeva EE; Gubenko EF; Kaulen DK; Zhdanov VM
    J Med Virol; 1980; 5(4):331-41. PubMed ID: 7229622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preparation and testing of a hepatitis B vaccine (author's transl)].
    Thomssen R; Gerlich W; Böttcher U; Stibbe W; Legler K; Weinmann E; Klinge O; Pfeifer U
    Dtsch Med Wochenschr; 1982 Jan; 107(4):125-31. PubMed ID: 7056165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and potency aspects in the preparation of an experimental HBsAg vaccine.
    Thomssen R; Gerlich WH; Böttcher U; Legler K; Ritter S; Stibbe W; Weinmann W; Klinge O; Pfeifer U
    Dev Biol Stand; 1983; 54():23-31. PubMed ID: 6228464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
    Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
    Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers.
    Dusheiko GM; Hoofnagle JH; Cooksley WG; James SP; Jones EA
    J Clin Invest; 1983 May; 71(5):1104-13. PubMed ID: 6602149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical structure of the hepatitis B surface antigen vaccine--I. Treatment of immobilized HBsAg by dissociation agents with or without enzymatic digestion and identification of polypeptides by protein blotting.
    Pillot J; Petit MA
    Mol Immunol; 1984 Jan; 21(1):53-60. PubMed ID: 6423972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new hepatitis B vaccine containing HBeAg in addition to HBsAg.
    Prince AM; Vnek J; Stephan W
    Dev Biol Stand; 1983; 54():13-22. PubMed ID: 6228452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An affordable multideterminant plasma-derived hepatitis B virus vaccine.
    Prince AM; Vnek J; Brotman B
    IARC Sci Publ; 1984; (63):355-72. PubMed ID: 6085626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active hepatitis B immunization with an experimental German vaccine. I. Immunogenicity studies in healthy adults. II. The primary 19 S and 7 S responses to HBsAg in healthy adults. III. Immunogenicity studies in hemodialysis patients.
    Scheiermann N; Kuwert EK
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):439-55. PubMed ID: 6485639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined immunoprophylaxis induces changes in anti-hepatitis B surface protein titer in infants born to mothers with positivity for hepatitis B surface antigen].
    Wang J; Feng YL; Liu MH; Bai Y; Feng DH; Yuan NX; Du DQ; Feng WH; Liu HL; Yang Y; Liu JF; He YL; Song HX; Liu Y; Zhao YR; Chen TY
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):580-3. PubMed ID: 24119736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity in chimpanzees of experimental hepatitis B vaccines prepared from intact hepatitis B virus, purified polypeptides, or polypeptide micelles.
    Tabor E; Howard CR; Skelly J; Snoy P; Goudeau A; Zuckerman AJ; Gerety RJ
    J Med Virol; 1982; 10(1):65-74. PubMed ID: 7130967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgM antibody responses to hepatitis B surface antigen in recipients of hepatitis B virus vaccine.
    Minuk GY; Hoofnagle JH; McAuliffe VJ; Purcell RH
    J Infect Dis; 1983 Aug; 148(2):330. PubMed ID: 6224865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies of the immunogenic activity of hepatitis B surface antigen (HBsAg) and HBsAg polypeptides.
    Sanchez Y; Ionescu-Matiu I; Melnick JL; Dreesman GR
    J Med Virol; 1983; 11(2):115-24. PubMed ID: 6842190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
    Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B vaccine: efficacy in high-risk settings, a two-year study.
    Maupas P; Goudeau A; Coursaget P; Drucker J; Bagros P
    Intervirology; 1978; 10(3):196-208. PubMed ID: 681144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of hepatitis B vaccine in chimpanzees given transfusions of highly infective blood.
    Karasawa T; Shikata T; Abe K; Horiuchi R; Takahashi T; Yoshihara N; Mayumi M; Suzuki H; Oda T
    J Infect Dis; 1983 Feb; 147(2):327-35. PubMed ID: 6827148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge.
    Payette PJ; Ma X; Weeratna RD; McCluskie MJ; Shapiro M; Engle RE; Davis HL; Purcell RH
    Intervirology; 2006; 49(3):144-51. PubMed ID: 16428890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A final report on safety and immunogenicity of a bivalent aqueous subunit HBV vaccine.
    Prince AM; Brotman B; Purcell RH; Gerin JL
    J Med Virol; 1985 Apr; 15(4):399-419. PubMed ID: 3156961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.